# Effect of OMM on Anandamide Levels in Saliva

> **NCT02727023** · NA · COMPLETED · sponsor: **New York Institute of Technology** · enrollment: 2 (actual)

## Conditions studied

- Anandamide
- Endocannabinoids

## Interventions

- **OTHER:** Osteopathic Manipulative Medicine

## Key facts

- **NCT ID:** NCT02727023
- **Lead sponsor:** New York Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-08
- **Final completion:** 2017-09
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02727023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02727023, "Effect of OMM on Anandamide Levels in Saliva". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02727023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*